CFTR and cystic fibrosis: Later, Firth and colleagues (Firth et al. 2015) generated iPSCs from CF patients with a homozygous deletion of CFTR F508 and corrected this mutation using CRISPR technology to target corrective sequences to endogenous CFTR genomic locus, combining with selection system.